▲ Peaking
Business
Psychedelics Stock, Up 190% This Year, Flies High Again
Definium Therapeutics surges after its LSD-based anxiety drug scores another successful Phase 3 trial.
2 trends tracked about this subject — the full history, oldest to newest below.
Definium Therapeutics surges after its LSD-based anxiety drug scores another successful Phase 3 trial.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.